| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,946 |
2,545 |
$384K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,122 |
1,901 |
$230K |
| G0378 |
Hospital observation service, per hour |
294 |
258 |
$86K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
7,903 |
6,341 |
$61K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
946 |
870 |
$56K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,727 |
1,239 |
$39K |
| 84484 |
|
3,482 |
2,546 |
$9K |
| 80053 |
Comprehensive metabolic panel |
5,096 |
3,948 |
$7K |
| 71045 |
Radiologic examination, chest; single view |
2,679 |
2,311 |
$7K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,882 |
4,251 |
$6K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
784 |
692 |
$4K |
| 70450 |
Computed tomography, head or brain; without contrast material |
944 |
868 |
$4K |
| 83735 |
|
3,146 |
2,300 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
49 |
47 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,477 |
1,116 |
$4K |
| 85610 |
|
2,054 |
1,677 |
$3K |
| 81001 |
|
1,175 |
1,044 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
96 |
81 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,137 |
3,115 |
$2K |
| 83690 |
|
1,081 |
969 |
$1K |
| 85730 |
|
181 |
167 |
$941.08 |
| 85027 |
|
177 |
148 |
$677.43 |
| 87088 |
|
172 |
157 |
$667.24 |
| 82948 |
|
1,911 |
1,122 |
$631.95 |
| 71046 |
Radiologic examination, chest; 2 views |
79 |
77 |
$595.44 |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
128 |
118 |
$492.52 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
998 |
766 |
$429.30 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
548 |
273 |
$398.03 |
| 81003 |
|
1,183 |
1,068 |
$341.13 |
| 83880 |
|
133 |
119 |
$231.81 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
12 |
12 |
$110.71 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
27 |
25 |
$105.94 |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
13 |
12 |
$88.73 |
| 94760 |
|
233 |
145 |
$30.32 |
| 83605 |
|
47 |
39 |
$18.18 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
29 |
26 |
$2.48 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
145 |
136 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
39 |
24 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
46 |
38 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
14 |
12 |
$0.00 |
| 85379 |
|
24 |
24 |
$0.00 |
| 82077 |
|
50 |
39 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
40 |
26 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
28 |
25 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
15 |
14 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
565 |
504 |
$0.00 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
12 |
12 |
$0.00 |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
12 |
12 |
$0.00 |